GOV.UK gov.uk 2026-06-09 12:26

Nipocalimab (Imaavy) authorised to treat adults and adolescents with generalised myasthenia gravis

As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review.

Read full article at GOV.UK ↗

This summary is provided by Daily Junction. The original article is published by GOV.UK and all rights remain with the original publisher.

Related coverage on Daily Junction

Daily Briefing

The day's biggest stories in one free email. Join 12,472 readers.